Key facts
- Notable investors include Zinc, Science Creates, Stevenage Bioscience Catalyst.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Native Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Native Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Native Labs
Operator of a bioprocess optimization platform intended to make cellular innovations more cost-effective to manufacture. The company integrates artificial intelligence-driven modeling and real-time control systems to predict optimal bioprocesses, precisely control bioreactors, and verify product quality in real-time, enabling clients to develop regenerative medicine and cultivated protein technologies more quickly and affordably.
- Sector
- Healthcare
- HQ
- Ilford, United Kingdom
- Founded
- 2023
- Employees
- 4
- Website
- nativelabs.ai/
- Ownership
- Privately Held (backing)
Native Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Native Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Native Labs in its N-PORT filings yet. We sweep new filings monthly.